Pauline Jen Ryan
Corporate Officer/Principal chez OCULAR THERAPEUTIX, INC.
Profil
Pauline Jen Ryan is currently the Head of Business and Corporate Development at Ocular Therapeutix, Inc. and a Partner at Red Sky Partners LLC.
She was previously the Chief Executive Officer at Verik Bio, Inc. from 2012 to 2017, the Senior Vice President of Corporate Development and Operations at ImmunoGen, Inc. from 1999 to 2007, and the Senior Vice President of Business Operations at Proteostasis Therapeutics, Inc. from 2007 to 2011.
She received her undergraduate degree from Northwestern University and her MBA from Kellogg School of Management.
Postes actifs de Pauline Jen Ryan
| Sociétés | Poste | Début |
|---|---|---|
| OCULAR THERAPEUTIX, INC. | Corporate Officer/Principal | - |
| Red Sky Partners LLC | Corporate Officer/Principal | 01/07/2014 |
Anciens postes connus de Pauline Jen Ryan
| Sociétés | Poste | Fin |
|---|---|---|
| Verik Bio, Inc. | Chief Executive Officer | 01/11/2017 |
| PROTEOSTASIS THERAPEUTICS, INC. | Corporate Officer/Principal | 01/08/2011 |
| IMMUNOGEN, INC. | Corporate Officer/Principal | 26/07/2007 |
Formation de Pauline Jen Ryan
| Northwestern University | Undergraduate Degree |
| Kellogg School of Management | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| IMMUNOGEN, INC. | Health Technology |
| OCULAR THERAPEUTIX, INC. | Health Technology |
| Entreprise privées | 3 |
|---|---|
Proteostasis Therapeutics, Inc.
 Proteostasis Therapeutics, Inc. BiotechnologyHealth Technology Proteostasis Therapeutics, Inc. operates as a clinical stage biopharmaceutical company. It engages in the discovery and development of novel therapeutics to treat cystic fibrosis (CF) and other diseases caused by an imbalance in the proteostasis network. The company was founded by William Balch, Jeffery W. Kelly, Andrew Dillin, Richard I. Morimoto, Alfred Lewis Goldberg, Daniel Finley, Christopher T. Walsh, and Randall W. King in 2006 and is headquartered in Boston, MA. | Health Technology |
| Red Sky Partners LLC | |
| Verik Bio, Inc. |
